Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $55.35 +3.32%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CBRS, MAYS, CRMT, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
